An in-depth look to PRESTIGE BIOLOGICS CO., LTD. operating, investing, and financing activities

334970 free cash flow for Q1 25 is -8.07 B KRW. For 2024, 334970 free cash flow was -16.87 B KRW and operating cash flow was -8.35 B KRW.